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Persistent p55TNFR expression 
impairs T cell responses during 
chronic tuberculosis and promotes 
reactivation
Ivy M. Dambuza1,†,*, Roanne Keeton1,*, Nai-Jen Hsu1, Nasiema Allie1,‡, 
Valérie F. J. Quesniaux2, Bernhard Ryffel2 & Muazzam Jacobs1,3,4
The pleiotropic activities of TNF are mediated by two structurally related but functionally distinct 
type I transmembrane receptors, p55TNFR and p75TNFR expressed in most cell types, that can be 
cleaved and act as TNF scavengers. Here, we investigated the effect of persistent p55TNFR cell surface 
expression during aerosol inhalation challenge with virulent M. tuberculosis H37Rv. We demonstrated 
that persistency of p55TNFR in macrophage cultures increased the synthesis of soluble TNF, p75TNFR 
and NO, however, had no effects on bacteria killing ability. Furthermore, it did not facilitate enhanced 
protection to primary acute M. tuberculosis infection in p55∆NS mice. Without exacerbated lung 
inflammation, we found a compensatory increase in p75TNFR shedding and decrease in bioactive 
TNF in BAL of p55∆NS mice after M. tuberculosis challenge. Defective expressions of CD44 and INFγ 
attributed to an impaired T cell response during persistent p55TNFR expression that caused marginal 
transient susceptibility during chronic infection. Moreover, persistent p55TNFR expression induced 
early reactivation during latent tuberculosis infection. These data indicate a prominent role of p55TNFR 
shedding in Th1 mediated protection against chronic and latent tuberculosis infection.
Tumor Necrosis Factor (TNF) is a member of the TNF superfamily (TNFSF), a class of structurally related 
cytokines that are involved in diverse immunological and developmental pathways1,2. Murine TNF is initially syn-
thesized as a 26 kDa glycosylated type II transmembrane molecule (Tm-TNF) that can be released from the cell 
surface by the metalloprotease TNF-α -converting enzyme (TACE) to generate a 17 kDa protein, and subsequent to 
homotrimerisation, a 51 kDa soluble TNF (solTNF) molecule is formed3–6. Both TNF forms are biologically active 
and their extensive biological effects are mediated by two receptors: p55TNFR (TNFRSF1A, CD120a, TNFR1) and 
p75TNFR (TNFRSF1B, CD120b, TNFR2) with Tm-TNF preferentially signaling through p75TNFR and solTNF 
binding strongly to p55TNFR7. Both receptors are type I transmembrane proteins sharing approximately 25% 
homology in their extracellular domains but have divergent cytoplasmic domains. Their extracellular domains can 
be released from the cell surface through proteolysis mediated by metalloproteases of the ADAM family, thereby 
generating soluble TNFRs capable of binding TNF8,9. Soluble TNFRs are thought to serve as (a) TNF antago-
nists, (b) TNF carrier proteins (c) a slow release reservoir for TNF, and as (d) stabilizers of TNF-bioactivity10 
and have been detected during various disease states including typhoid fever11, malaria12, sub-acute bac-
terial endocarditis13 and visceral leishmaniasis14, and mycobacterial infections including tuberculosis15–17. 
Numerous clinical studies have demonstrated increased serum TNF receptors concentrations, associated with 
severity of M. tuberculosis disease18,19. TNF shares its receptors with Lymphotoxin (LT); in its homotrimeric form 
LTα interacts with TNFRp55 and p75 while the LTα LTβ heterotrimers, interact with LTβ -R20.
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TNF gene deletion21–24, p55TNFR gene deletion16,25,26, and TNF neutralization studies27,28 demonstrated 
TNF-TNFR signaling as critical for protective immunity against mycobacterial infections. In the absence 
of TNF-p55TNFR signaling, challenge of mutant mice with either attenuated M. bovis BCG29 or virulent 
M. tuberculosis21,24,25 resulted in elevated bacterial burdens, impaired granuloma structure formation and early 
death. Owing to its strong pro-inflammatory and immunostimulatory activities, the duration and amplitude of 
TNF functions are tightly regulated. One mechanism, which controls bioavailability of TNF, is p55TNFR and 
p75TNFR shedding. Both soluble p55TNFR and p75TNFR are found in the lung of M. tuberculosis infected 
patients and mice15,16,30,31. However, virulent pathogens such as M. tuberculosis H37Rv and M. avium can actively 
manipulate this system to evade the immune response15,16,32. Indeed, we showed recently that a major role of 
p75TNFR in mycobacterial infection control seems to be through its shed soluble form, which effectively regulate 
the level of bioactive TNF that contributes to the disease outcome16. Patients treated with TNF inhibitors includ-
ing Etanercept, a p75TNFR IgG fusion protein show a marked increased risk for TB infection33.
Here we address the specific role of shed, soluble p55TNFR in host control of M. tuberculosis infection. The 
generation of a nonsheddable p55TNFR (p55ΔNS) mouse strain has provided insight into the roles of both the sol-
uble and the membrane-bound forms of p55TNFR in pathogenesis of infectious, inflammatory and autoimmune 
diseases. Xanthoulea and colleagues indicated that mice expressing a mutated nonsheddable form of p55TNFR 
(p55∆NS) developed a Toll-like receptor dependent innate immune hyper responsiveness34. In this mouse model 
p55TNFR is rendered nonsheddable on all cell types which express p55TNFR. We thus investigated the role of 
signaling and regulatory effects of nonsheddable p55TNFR in host immunity against M. tuberculosis. We report 
here after M. tuberculosis aerosol exposure that p55∆NS mice expressing nonsheddable p55TNFR controlled acute 
infection similar to their WT counterparts while they exhibited a transient loss of control during chronic infec-
tion and an increased susceptibility to reactivation of latent tuberculosis.
Results
Sustained p55TNFR surface expression in p55∆NS peritoneal elicited cells after M. tuberculosis 
infection. Numerous studies have demonstrated release of TNFRs after infection or immunization in vitro 
and in vivo15,16. TNFR shedding from cell surfaces coincides with the generation of TNF16,17; its functional sig-
nificance being associated with the regulation of TNF mediated effects35–38. Xanthoulea and colleagues showed 
that upon activation with PMA, peritoneal exudate cells derived from p55∆NS mice expressed a nonsheddable 
p55TNFR34. Here, we investigated the relationship between p55TNFR expression and M. tuberculosis infection. 
Thioglycollate elicited macrophages from WT mice or p55∆NS mice were exposed to M. tuberculosis H37Rv for 
20 minutes and p55TNFR cell surface expression determined by flow cytometry. p55TNFR expression occurred 
in both WT and p55∆NS unstimulated macrophages (Fig. 1a). However, exposure to M. tuberculosis H37Rv caused 
a loss of p55TNFR surface expression on WT macrophages (reflected by reduced Mean Fluorescent Intensity) 
compared to the elevated and sustained expression noted in p55∆NS macrophages (Fig. 1a). Quantification of the 
cleaved p55TNFR revealed detectable levels of soluble p55TNFR present in unstimulated culture supernatants of 
thioglycollate elicited macrophages from WT mice, which increased significantly at all the time points (p < 0.01) 
after activation with LPS (Fig. 1b) and increased significantly at 90 and 150 minutes after viable M. tuberculosis 
H37Rv (Fig. 1c) infection (p < 0.01). No soluble p55TNFR was detected in supernatants of p55∆NS macrophages 
before or after stimulation.
The data confirms sustained expression of p55TNFR in p55∆NS mice and demonstrate that p55TNFR shedding 
is induced by M. tuberculosis.
Enhanced macrophage bactericidal potential does not correlate with increased bacilli killing in 
the presence of sustained p55TNFR expression. We hypothesized that sustained p55TNFR expression 
may allow for continued or amplification of TNF signalling yielding improved control of infection. To determine 
how sustained membrane p55TNFR expression influences restriction of bacterial replication, we investigated 
the bactericidal potential and bacterial killing in bone marrow derived macrophages (BMDM). Unlike the thi-
oglycolate elicited macrophages, BMDM primary cultures represent a more naïve homogeneous macrophage 
population which can be stimulated and activated under different experimental conditions. These BMDM’s from 
WT mice and p55∆NS mice were pre-activated with (equimolar) 100 U/mL IFNγ concentrations for 24 hours to 
achieve optimal macrophage activities similar to those during inflammation, in particular the NO production 
by active macrophages. This requirement for IFNγ pre-activation was confirmed by initial optimization studies 
in which nitrite production were below the baseline without IFNγ pre-stimulation (Supplementary Fig. 1). TNF 
and nitric oxide (NO) levels were quantified following stimulation with LPS or M. tuberculosis H37Rv. Consistent 
with published data34, stimulating p55∆NS derived macrophages with 100 ng/ml LPS increased TNF synthesis in a 
time-dependent manner with a significant increase (p < 0.05) observed 300 minutes post stimulation compared 
to WT derived macrophages (Fig. 2a). Similarly, significantly higher TNF production was observed in p55∆NS 
derived macrophages when challenged with M. tuberculosis H37Rv, however TNF concentrations were found to 
be approximately 10 fold less compared to LPS stimulation (Fig. 2d).
TNF and IFNγ synergize for optimum macrophage activation resulting in production of the effector molecule 
NO39,40, which can be measured relatively by the Griess Reagent System to determine the nitrite (NO2−) concen-
tration as one of two primary stable breakdown products of NO. Therefore, we quantified nitrite concentrations in 
supernatants of activated macrophages and found levels significantly enhanced (p < 0.05) in p55∆NS derived mac-
rophages relative to WT controls after stimulation with LPS for 48 hours (Fig. 2c). Similar results were attained 
when macrophages were stimulated with M. tuberculosis H37Rv, with a significant increase in nitrite concentra-
tion (p < 0.001) as early as 24 hours after stimulation and a further increase in NO synthesis (p < 0.05) observed 
48 hours later in p55∆NS mice compared to WT mice (Fig. 2f). Therefore, the increased synthesis of TNF and NO 
in p55∆NS macrophages points to a heightened state of macrophage activation and bactericidal potential. On the 
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contrary, M. tuberculosis-GFP bacilli killing assays revealed no significant enhancement of bactericidal ability in 
p55∆NS macrophages compared to WT macrophages (Fig. 2g).
Both TNFRs are proteolytically cleaved from the cell surface in the presence of inflammatory stimuli and the 
levels of soluble TNFRs are thought to modulate TNF responsiveness. We and others have shown that increased 
shedding implied a more dominant role for p75TNFR in regulating the bioactivity of TNF16,41. To determine 
whether there was a difference in p75TNFR shedding between WT and p55ΔNS derived macrophages, the levels 
of soluble p75TNFR were also quantified in the supernatants after stimulation with LPS or M. tuberculosis H37Rv. 
Results showed that p55ΔNS derived macrophages produced significantly higher levels (p < 0.01) of soluble 
p75TNFR when stimulated with either LPS (Fig. 2b) or M. tuberculosis H37Rv (Fig. 2e) for 300 minutes. To ascer-
tain whether p75TNFR shedding affects the bioactivity of TNF in p55ΔNS mice, we challenged the mice with M. 
tuberculosis H37Rv by aerosol inhalation. Here we found higher levels of p75TNFR and lower levels of bioactive 
TNF in the bronchoalveolar lavage (BAL) fluid of p55ΔNS mice compared to WT mice at both day 3 and day 6 
post-infection (Fig. 2h,i) that corroborates our previous findings16. These data suggest that defective p55TNFR 
shedding results in significant increased release of soluble p75TNFR as a compensatory mechanism with poten-
tial to modulate TNF activity.
Sustained expression of surface p55TNFR does not enhance mycobactericidal responses during 
acute in vivo M. tuberculosis infection. The abrogation of TNF-p55TNFR signaling, either genetically or 
with neutralizing antibodies, results in susceptibility to mycobacterial and other intracellular infections21,25,28,42. 
Figure 1. Sustained p55TNFR cell surface expression in p55∆NS cells. Thioglycollate elicited peritoneal 
macrophages from p55∆NS and WT mice were stained with anti-p55TNFR before stimulation (black histogram) 
or after 20 minutes stimulation with M. tuberculosis H37Rv (MOI = 2:1) and analyzed by flow cytometry 
to determine p55TNFR cell surface expression (a) (red histogram, MFI loss indicates receptor shedding). 
Activation induced soluble p55TNFR cleavage was observed in WT but not p55∆NS cells. Thioglycollate 
elicited peritoneal macrophages were isolated from WT mice (closed squares represent resting cells and closed 
circles represent stimulated cells) and p55∆NS mice (open squares represent resting cells and open circles show 
stimulated cells) and stimulated with 100 ng/ml LPS (b) or M. tuberculosis H37Rv (MOI = 2:1) (c). Soluble 
p55TNFR accumulation in the supernatants was determined by ELISA at time points indicated. Data are 
expressed as mean ± SD triplicate values and results represent 1 of 2 experiments performed. Statistical analysis 
compared resting and stimulated macrophages and was performed by ANOVA (*p < 0.05, **p < 0.01).
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Specific functions attributable to soluble and membrane TNFRs in various infections and disease states are still 
not fully understood. In both mice and humans, defective p55TNFR shedding resulted in enhanced sensitivity to 
TNF mediated immunopathology43,44. Xanthoulea and colleagues reported enhanced innate immune activation 
in p55∆NS mice, which mediated increased resistance to L. monocytogenes infection in vivo and suggested that 
persistently expressed membrane p55TNFR conferred enhanced protective antibacterial immunity34. In con-
sideration of these results, we addressed the in vivo functional role of membrane bound p55TNFR and receptor 
shedding during M. tuberculosis H37Rv infection. WT mice and p55∆NS mice were exposed to a low dose aerosol 
inhalation infection of 50–100 CFUs/mouse M. tuberculosis H37Rv and pulmonary bacilli burdens were assessed 
over 8 weeks. Results showed that p55ΔNS mice controlled acute infection with comparable kinetics to WT mice 
reflected by equivalent bacilli numbers in the lungs (Fig. 3a) at all the acute time points investigated. We also 
observed similar degrees of pulmonary inflammation in terms of comparable lung weights (Fig. 3b) and total 
Figure 2. Enhanced TNF, Nitric Oxide and TNFRp75 production in macrophages expressing a non-
sheddable form of p55TNFR. Bone marrow derived macrophages isolated from WT mice (closed circles) and 
p55∆NS mice (open circles) were prestimulated with 100 U/ml IFNγ for 24 h prior stimulation with 100 ng/ml  
LPS (a–c) or M. tuberculosis H37Rv (d–f), (MOI = 2:1). The kinetics of soluble TNF (a,d) and TNFRp75 
(b,e) accumulation in the supernatants was measured by ELISA, and the production of NO was quantified 
by measuring the nitrite concentration using Griess reagent (c,f). Macrophage bactericidal capacity to kill 
M. tuberculosis bacilli was analysed by measuring relative fluorescent unit (RFU) in H37Rv-GFP infected 
macrophages using the GFP-microplate assay (g). The levels of soluble p75TNFR (h) and bioactive TNF (i) were 
measured in the BAL fluids of WT (closed bars) and p55∆NS mice (open bars) at 3 and 6 days after M. tuberculosis 
infection. Results represent 1 of 3 similar experiments and data are expressed as mean ± SD of triplicate values. 
Statistical analysis was performed by ANOVA (*p < 0.05, **p < 0.01, ***p < 0.001).
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cell counts of the lung (Fig. 3c). Further, pulmonary pathology was qualitatively equivalent with no differences in 
cellular infiltration or granuloma formation (Fig. 3d). Thus sustained p55TNFR expression does not enhance the 
bactericidal capacity of the host during acute M. tuberculosis infection.
Figure 3. Persistent membrane p55TNFR expression does not enhance control of mycobacterial 
replication during acute infection. WT mice (closed circles) and p55∆NS mice (open circles) were challenged 
by aerosol inhalation with 50–100 CFUs/mouse with M. tuberculosis H37Rv. Bacilli burdens were enumerated 
in the lungs (a) at time points indicated above. Lung weights (b) were recorded at 21 and 28 days post-
infection as a surrogate marker of infllamation. Total pulmonary cell numbers (c) were determined at 21 days. 
Histopathology was assessed by (h,e) staining of formalin-fixed lung (d). Data are representative of 3 similar 
experiments. Results are expressed as mean ± SD of 4 animals/group. Statistical analysis was performed by 
ANOVA (*p < 0.05, **p < 0.01, ***p < 0.001).
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Macrophage function is not enhanced in the presence of sustained p55TNFR expression 
in vivo during acute M. tuberculosis infection. To understand how persistent p55TNFR expression 
affects macrophage function in vivo we measured and compared recruitment of CD11b+ cells to the lungs and 
their activation state in M. tuberculosis-infected WT mice and p55ΔNS mice. Flow cytometric analyses of pulmo-
nary cells revealed equivalent frequencies of CD11b+ cell recruitment in p55∆NS mice compared to WT mice 
at day 21 post-infection (Fig. 4a,b; Gating strategy in Supplementary Fig. 2). To determine macrophage activa-
tion under conditions of sustained p55TNFR presence, we analyzed the frequencies of CD11b+MHC-II+ cells 
as well as the MFIs of cell surface MHC-II, CD80 and CD86 expression on CD11b+ cells in the lungs at 21 days 
post-infection. p55ΔNS mice displayed comparable CD11b+MHC-II+ cells compared to WT mice 21 days post 
infection (Fig. 4c). The number of CD11b+CD80+ and CD11+CD86+ cells as well as the MFIs of MHC-II, CD80 
and CD86 expressed on CD11b+ cells was also found to be equivalent in both strains (Data not shown). The data 
indicate that persistent membrane p55TNFR expression does not enhance the expression of costimulatory mol-
ecules on CD11b+ cells.
To determine the influence of persistent p55TNFR expression on macrophage function in vivo, IL-12p70, 
NO and TNF concentrations were measured in the lungs of M. tuberculosis-infected WT mice and p55∆NS 
mice. IL-12p70 and TNF are critical mediators of anti-mycobacterial immunity and primarily synthesized by 
macrophages45–49. TNF levels in p55∆NS mice were significantly higher (p < 0.05) at day 21 compared to WT mice 
(Fig. 4d), while IL-12p70 concentrations showed a non-significant trend towards enhancement in p55∆NS mice 
compared to WT mice at 21 days post-infection but was significantly reduced si at day 28 (Fig. 4e). NO levels in 
lung homogenates of p55∆NS mice were significantly lower (p < 0.001) compared to WT mice at 28 and 49 days 
post-infection (Fig. 4f). Collectively the data indicates that sustained p55TNFR expression does not enhance 
macrophage activation.
Th1 immune activation is impaired in p55∆NS mice. As a key determinant of disease outcome we inves-
tigated whether sustained p55TNFR expression influences Th1 immune function. Here, we first evaluated the 
influx and activation state of CD4+ T-cells in the lungs of infected WT mice and p55∆NS mice by flow cytometry. 
CD44 and IFNγ were used as markers of T cell activation. CD44 is a cell adhesion receptor and wildly distributed. 
Figure 4. Similar expression of CD11b+/MHC-II+ cells and increased TNF and IL-12p70 expression 
in the lungs of M. tuberculosis infected p55∆NS mice. WT mice (closed bars) and p55∆NS mice (open bars) 
were infected by aerosol inhalation with 50–100 CFUs/mouse M. tuberculosis H37Rv. Single cell suspensions 
were generated from PBS-Heparin perfused lungs at day 21 post-infection, stained and analyzed for CD11b 
and MHC-II expression by flow cytometry. Representative dot plots representing flow cytometry analysis of 
CD11b+ cells (a) obtained from the infected lungs of WT mice. Percentages of pulmonary CD11b+ (b) and 
CD11b+/MHC-II+ (c) cells are presented. For cytokine expression, lungs were isolated and homogenized 
at days 21 and 28 post-infection and the levels of TNF (d) and IL-12p70 (e) were quantified by ELISA. The 
production of NO was quantified by measuring the nitrite concentration using Griess reagent (f). Data represent 
1 of 3 experiments performed and results are expressed as mean ± SD from 4 mice/group. Statistical analysis was 
performed by ANOVA (*p < 0.05, **p < 0.01, ***p < 0.001).
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Ligation of CD44 with hyaluronanis results in a variety of downstream responses that includes cell adhesion, cell 
migration, and hematopoietic process. In mature lymphocytes, CD44 is upregulated in response to antigenic 
stimuli and represents the effector stage of immunological responses50–52. The use of CD44 as marker for effector 
T cells is generally accepted and demonstrated in various fields of studies16,53,54. Comparable frequencies of CD4+ 
T cells were present between the two strains at both day 14 and day 21 post-infection (Fig. 5a,b; Gating strategy 
in Supplementary Fig. 2), Interestingly while equivalent frequencies of pulmonary CD4+CD44+ T cells were 
measured in both strains 14 days and 21 days post-infection (Fig. 5c), the MFI of cell surface CD44 expression 
gated on CD4+ T cells was lower in p55∆NS mice compared to WT mice, significantly so (p < 0.05) at day 14 
post-infection (Fig. 5d,e). The data illustrate that despite the comparable CD4+ T cell recruitment to lungs of WT 
mice and p55∆NS mice, persistent p55TNFR expression might play a suppressive role in T cell activation during 
early infection.
We next compared the kinetics of IFNγ production in the lungs of infected WT mice and p55∆NS mice as a 
further measurement of in vivo T cell functionality. We observed lower IFNγ concentrations with significant dif-
ferences at day 21 (p < 0.05) and day 28 (p < 0.01) post-infection in p55∆NS mice compared to WT mice (Fig. 5f). 
The data suggest that persistent p55TNFR expression may suppress pulmonary T cell activation which associates 
with reduced IFNγ production.
Sustained expression of surface p55TNFR results in marginally impaired bactericidal responses 
during chronic in vivo M. tuberculosis infection. We postulated that a dysregulated Th1 immune 
response in p55∆NS mice may compromise long term host protective immunity during a primary infection. 
Therefore, to determine the effect of sustained p55TNFR expression on disease outcome during chronic stages 
of a primary infection, M. tuberculosis infected p55∆NS mice and WT mice were monitored for > 500 days. The 
bacilli burdens of p55∆NS mice were higher than those of WT mice at 180 days post-infection and, although mod-
erate, was nonetheless significantly lower at 300 days post-infection (p < 0.05) (Fig. 6a) which correlated with a 
non-significant trend towards more rapid death in p55∆NS mice as compared to WT controls, where WT mice had 
an increased medium survival of 476 days compared to 395 days in p55∆NS mice (Fig. 6b). Although the analysis 
of total lung cell counts (Fig. 6d) and free alveolar space (Fig. 6e) showed no statistical difference, we observed a 
transient increase in lung histopathology (Fig. 6f) at 180 days, which was quantitatively confirmed by an increase 
in lung weights (Fig. 6c) at this time point in p55∆NS mice.
The data therefore indicates that persistent p55TNFR surface expression compromises protection against 
chronic M. tuberculosis infection.
Sustained expression of surface p55TNFR results in loss of control against reactivation of 
latent mycobacterial infection. Our data demonstrated that persistent p55TNFR expression might play a 
suppressive role in T cell activation, we next assessed the quality of the T cell response generated in a reactivation 
challenge model. The rationale was that defects in the development of a fully functional T cell response during the 
primary infection might compromise the ability of M. tuberculosis specific T cells to protect against reactivation 
of a latent infection. Infected p55∆NS mice and WT mice were treated with rifampicin and isoniazid for 6 weeks, 
beginning at day 28 post-infection to induce a state of latency and were subsequently assessed at 90, 180, 300 days 
for reactivation of tuberculosis. Similar to our earlier finding, the acute phase of latent infection showed no dif-
ferences in CFU burdens (Fig. 7a). Low bacilli burdens measured at 90 days post-infection confirmed successful 
chemotherapy in both strains. However p55∆NS mice showed enhanced reactivation of disease with significantly 
higher bacilli burdens by 300 days (Fig. 7a) accompanied by significantly higher lung weights (Fig. 7b) compared 
to WT control mice. Despite the equivalent numbers of total lung cells (Fig. 7c) and percentages of free alveolar 
space (Fig. 7d), we observed microscopically higher degree of inflammation in the lung of p55∆NS mice than in 
WT mice (Fig. 7e).
To further assess the effects of persistent p55TNFR expression on p75TNFR levels and the cytokine produc-
tions during reactivation of latent M. tuberculosis infection, we compared the levels of TNF, p75TNFR, NO and 
IL-12p70 in the lungs of WT mice and p55∆NS mice at 90 and 300 days post-infection. Both TNF and p75TNFR 
levels in p55∆NS mice were similar to WT mice at day 90 but significantly increased at day 300 (p < 0.05) 
(Fig. 8a,b). Nitrite concentrations in p55∆NS infected lungs were significantly lower at day 90 (p < 0.05) but higher 
at day 300 (p < 0.05) than the WT lungs (Fig. 8c), Pulmonary IL-12p70 concentrations were reduced significantly 
(p < 0.01) in p55∆NS mice at both day 90 and 300 (Fig. 8d).
We next assessed the quality of the T cell response generated during latent infection by analyzing the acti-
vation state of CD4+ T-cells in infected lungs after 6 weeks of rifampicin and isoniazid treatment, and a further 
3 weeks of infection reactivation. While comparable frequencies of pulmonary CD4+ T cells were present 
between the two strains at 90 days post-infection (Fig. 9a,b), the frequencies of pulmonary CD4+CD44+ T cells 
were reduced in p55∆NS mice (Fig. 9a,c). The MFI of cell surface CD44 gated on CD4+ T cells was also signifi-
cantly lower in p55∆NS mice compared to WT mice (Fig. 9d,e). Moreover, we observed significantly lower IFNγ 
concentrations in p55∆ NS mice compared to WT mice (Fig. 9f).
Together the data indicates an inability of p55∆NS mice to control reactivation of latent tuberculosis, which 
may be linked to the fact that persistent p55TNFR expression suppresses effector T cell activation during latent 
infection.
Discussion
TNF-p55TNFR mediated signaling is a critical requirement for control and resolution of mycobacterial infec-
tion21,22,28,29. The widespread expression of TNFRs on different cell types and tissues55–57 indicates the spectrum 
breath of target cells with which TNF can interact and necessitates tight regulation around the TNF-TNFR sig-
naling axis. TNF mediated activities are controlled by multiple regulatory mechanisms including proteolytic 
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Figure 5. T cell responses in the presence of persistent membrane p55TNFR expression. WT mice (closed circles/
bars) and p55∆NS mice (open circles/bars) were infected by aerosol inhalation with 50–100 CFUs M. tuberculosis 
H37Rv. Representative dot plots of flow cytometry analysis showing CD4+CD44+ cells (a) obtained from the infected 
lungs of WT mice. Pulmonary single cells suspensions from PBS-Heparin perfused lungs were analyzed for CD4+ 
(b) and CD4+CD44+ (c) expression, and the CD44 MFI (d and representative from day 14 in (e): IgG control – green, 
WT – red, p55∆NS - blue) calculated. For pulmonary cytokine expression, IFNγ (f) synthesis was quantified by ELISA. 
Results represent 1 of 2 experiments performed and data are expressed as mean ± SD of 4 mice/group. Statistical 
analysis was performed by ANOVA (*p < 0.05, **p < 0.01, ***p < 0.001).
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shedding of TNFRs from cell surfaces. The resultant soluble p55TNFR and p75 bind TNF, competing with cell 
surface receptors and limit TNF function in target cells35–38. We and others have shown TNFRp55 mediated TNF 
signaling to be essential to generate host immune protection, while shed, soluble p75TNFR has a critical role in 
regulating TNF bioavailability15,16. Clinically, increased soluble p55TNFR and p75TNFR has been associated with 
exacerbated M. tuberculosis disease severity18,19,30. In humans, specific missense mutations in the p55TNFR gene 
that cause defective receptor shedding strongly associate with autosomal dominant periodic fever syndromes 
known as TRAPS44, and are thought to be primarily caused by irregular innate immune function in these patients. 
The effects of persistent membrane TNFR expression, in the absence of the shed form, within disease settings are 
unknown.
In this study, we investigated the functional relevance of persistent p55TNFR cell surface expression and 
impaired p55TNFR shedding during infection with M. tuberculosis H37Rv using a mutant mouse strain (p55∆NS) 
with p55TNFR wild type receptor functionality but defective shedding capability34. We confirmed that p55TNFR 
Figure 6. Persistent membrane p55TNFR expression causes in increased bacterial burden and increased 
sensitivity during chronic infection. WT mice (closed circles) and p55∆NS mice (open circles) were challenged by 
aerosol inhalation with 50–100 CFUs/mouse with M. tuberculosis H37Rv. Bacilli burdens were enumerated in the 
lungs (a) at time points indicated above. Mortality rates were monitored over the indicated infection period (n = 11) 
(b). At 180 and 300 days post-infection lung weights were recorded as a surrogate marker of inflammation (c) and 
total pulmonary cell counts determined (d). Histopathology was assessed by (h,e) staining of formalin-fixed lungs 
(f) and subsequent analysis of free alveolar space (e). Additional magnified images (200X) of the granulomatous 
regions were also included in (e). Data are representative of 2 similar experiments. Results are expressed as 
mean ± SD of 4 animals/group. Statistical analysis was performed by ANOVA (a,c,d,e) or Logrank (b) (*p < 0.05, 
**p < 0.01, ***p < 0.001).
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and p75TNFR are released from the cell surface prior to and after macrophage activation with either LPS or 
viable M. tuberculosis H37Rv bacilli, in agreement with previous reports demonstrating that soluble TNFRs are 
generated after cell activation58–60. Moreover, our results show that both constitutive and M. tuberculosis induced 
shedding are inhibited in p55∆NS derived cells, correlating with persistency of p55TNFR cell surface expression. 
Interference of the TNF-p55TNFR signaling pathway either by gene deletion of ligand or receptor, or by neutral-
izing antibodies leads to susceptibility to mycobacterial and other intracellular pathogens21,29,61–63. We hypoth-
esized that persistent cell surface p55TNFR expression would result in enhanced TNF-p55TNFR interaction 
leading to improved disease outcome. In contrast, our data demonstrate that persistent cell surface p55TNFR 
expression does not confer a protective advantage against M. tuberculosis H37Rv infection in either acute or 
chronic infection. We have previously reported that treatment of WT dendritic cells with recombinant p75TNFR 
Figure 7. Persistent membrane p55TNFR expression induces loss of control during latent M. tuberculosis 
infection. WT mice (closed circles/bars) and p55∆NS mice (open circles/bars) were challenged by aerosol 
inhalation with 50–100 CFUs/mouse with M. tuberculosis H37Rv. Latency was achieved by treatment with 
RIF/INH (25 mg/kg) for 6 weeks commencing at day 28 post-infection (Red lines marked as T in a). Bacilli 
burdens were enumerated in the lungs (a) at time points indicated above. At 180 and 300 days post-infection 
lung weights were recorded as a surrogate marker of inflammation (b) and total pulmonary cell counts analyzed 
(c). Histopathology was assessed by (h,e) staining of formalin-fixed lungs (e) and subsequent analysis of free 
alveolar space (d). Additional magnified images (200X) of the granulomatous regions were also included in 
(e). Data are representative of 2 similar experiments. Results are expressed as mean ± SD of a minimum of 4 
animals/group. Statistical analysis was performed by ANOVA (*p < 0.05, **p < 0.01, ***p < 0.001).
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reduced bioactive TNF levels which resulted in impaired dendritic cell activation. In contrast treatment with 
anti-p75TNFR had the opposite effect with increased bioactive TNF translating to enhanced dendritic cell acti-
vation16. We would therefore postulate an enhanced protection in these p55∆NS mice by blocking its p75TNFR 
to increase macrophage activation and killing ability. Although the p55∆NS macrophages from our in vitro exper-
iments exhibited better bactericidal potential, the p55∆NS mice failed to demonstrate improved bacterial con-
trol, which was expected considering the similar in vitro bacilli killing abilities in WT and p55∆NS macrophages. 
However caution must be exercised when directly comparing in vitro and in vivo data; the antigen presenting 
cells (APC’s) in the lungs are comprised of a more complex array of cells which include inflammatory monocytes, 
alveolar macrophages and dendritic cells. The alveolar macrophages are the key cells to first line defense against 
M. tuberculosis in the lung; however they are not the ideal cell type for our in vitro experiments to study bacilli 
killing. We used IFNγ activated BMDM’s resembling inflammatory monocytes, whose primary immune function 
is bacilli killing during infections.
We found that mice expressing the mutant persistent cell surface receptor succumbed to M. tuberculosis  
chronic infection earlier than the WT group with a significant increase in bacilli burdens. The p55∆NS mice 
also demonstrated a loss of bacilli control resulting during latent infection. These data demonstrate that the 
host protection against tuberculosis infection was not improved during persistent p55TNR expression as ini-
tially hypothesized. These findings contrasted earlier studies which reported that challenging p55∆NS mice with 
increasing doses of L. monocytogenes results in improved host resistance compared to control animals. Under 
such conditions sustained p55TNFR expression enhanced antibacterial host mechanisms and suggested that L. 
monocytogenes might evoke p55TNFR shedding as an immune escape mechanism34. This contrast highlights the 
differences in the pathogenesis and immunity of these two pathogens. For example, the functions of membrane 
TNF has been studied in both listeria and tuberculosis disease models. Using the mice with noncleavable mem-
brane TNF (mem-TNF) Torres et al. showed partial protection against Listeria in a dosage dependent manner64. 
On the other hand, Fremond et al. reported that the mem-TNF mice were protected from the Mycobacterium 
tuberculosis acute infection but not the chronic infection65.
We investigated host immune responses in p55∆NS mice to gain deeper understanding of immune function 
during M. tuberculosis infection. We found that pulmonary cellular recruitment did not increase over the course 
of infection in p55∆NS mice relative to control animals. This outcome was interesting, as TNF is known to be 
a master orchestrator of inflammation. Closer inspection of the lung cell populations during early infection 
Figure 8. Cytokine productions in mice expressing non-sheddable form of p55TNFR during reactivation 
of latent infection. Lungs were isolated from WT mice (closed bars) and p55∆NS mice (open bars), 
homogenized at day 90 and 300 post-infection, and the levels of TNF (a), p75TNFR (b) and IL12p70 (d) 
were quantified by ELISA and Nitrite (c) was quantified by Griess reagent. Results represent 1 of 3 similar 
experiments and data are expressed as mean ± SD of triplicate values. Statistical analysis was performed by 
ANOVA (*p < 0.05, **p < 0.01, ***p < 0.001).
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Figure 9. Reduced effector T cells in the lungs of latently M. tuberculosis infected p55∆NS mice. WT mice 
(closed bars) and p55∆NS mice (open bars) were infected by aerosol inhalation with 50–100 CFUs/mouse of  
M. tuberculosis H37Rv. Latency was achieved by treatment with RIF/INH (25 mg/kg) for 6 weeks commencing 
at day 28 post-infection. Single cell suspensions were generated from PBS-Heparin perfused lungs at day 90 
post-infection, stained and analyzed for CD3, CD4, and CD44 expression by flow cytometry. Representative dot 
plots depicting flow cytometry analysis of CD4+ and CD4+/CD44+ cells (a) obtained from the infected lungs 
of WT and p55∆NS mice. Percentages of pulmonary CD4+ cells (b) and CD4+CD44+ effector T cells (c) were 
determined. The MFI of CD44 gated on CD4+ T cells is depicted in (d) with a representative histogram overlay 
in E (IgG control – green, WT – red, p55∆NS - blue). Data represent 1 of 2 experiments performed and results are 
expressed as mean ± SD of 5 mice/group. Statistical analysis was performed by ANOVA (*p < 0.05, **p < 0.01, 
***p < 0.001).
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revealed a transient increase in the frequency of CD11b+/MHC-II+ expressing cells in mice persistently express-
ing p55TNFR, however these cells displayed a state of activation equivalent to WT control mice. Moreover, we 
found persistent p55TNFR expression associated with defective pulmonary IFNγ synthesis correlating with a 
decrease in CD4+ T cell activation despite normal pulmonary CD4+ T cell recruitment. Collectively, our find-
ings suggest that persistent p55TNFR expression induces hypo-immune response during M. tuberculosis. This is 
in line with the fact that I T cell hybridoma clones exposed to chronic TNF stimulation down regulated TCRζ 
and TCR/CD3 complex cell surface expression, leading to T cell hyporesponsiveness reflected by a decrease in 
antigen-specific proliferation and suppression of cytokine responses66. The authors further demonstrated that the 
observed T cell hyporesponsiveness was mediated via p55TNFR66. Persistent p55TNFR signaling also led to down 
modulation of T cell responses in a model of chronic inflammation involving TCR transgenic mice67. Collectively 
the data supports a mechanism by which T cell activation is regulated in a p55TNFR dependent manner during 
chronic M. tuberculosis infection. This is likely indirect, as we showed recently that the p55TNFR pathway in 
T cells is dispensable for controlling M. tuberculosis infection26. However, given our previous published data 
in which we demonstrated an increased p75TNFR shedding in the absence of p55TNFR resulting in reduced 
bioactive TNF16, we hypothesized that a similar compensationary increase in p75TNFR in the non-sheddable 
p55TNFR mouse strain and subsequent reduced bioactive TNF levels may be the underlying mechanism driving 
the observed T cell hyporesponsiveness in the p55∆NS mice. Indeed an analysis of soluble p75TNFR both in vitro 
in bone marrow derived macrophages as well as in vivo in BAL fluid samples, demonstrated an increased level of 
soluble p75TNFR in p55∆NS mice compared to WT mice which we confirmed in vivo to induce impaired bioactive 
TNF concentrations. We have also previously shown that bioactive TNF signaling through p55TNFR in dendritic 
cells plays an important role in IL-12 dependent DC migration to the draining lymph node and subsequent M. 
tuberculosis-specific T cell activation16. It is therefore possible that disruption of p55TNFR shedding leads to a 
compensationary increase in soluble p75TNFR which reduces bioavailable TNF and impairs dendritic cell migra-
tion, all of which results in defective Th1 responses.
Our hypothesis of a potential defect in T cell responses during persistent p55TNFR expression was indeed 
validated when p55∆NS mice displayed enhanced sensitivity to tuberculosis reactivation. The mechanism 
associated with defective T cell responses during chronic tuberculosis is unknown. Given the similar frequencies of 
T cell recruitment, a reduction in T cell proliferation is unlikely to be the cause of defective T cell responses. This 
opens the possibility to a potential role for regulatory T cells (Tregs) in the suppressed CD4+CD44+ T cell acti-
vation during persistent p55TNFR expression. Previous studies have indicated that neutralization of TNF during 
rheumatoid arthritis treatment elicited a significant population of Tregs. And the ablation of p55TNF in reactive 
arthritis mice resulted in a reduced Tregs number and activity indicate that TNF signaling through p55TNFR and 
p75TNFR is important to the regulation of Treg cell function68,69. Another possible mechanism associated with 
defective T cell responses might be that sustained p55TNFR signaling induces T cell exhaustion. Recently, Beyer 
et al., reported reversal of T cell exhaustion through TNF neutralization which reconstituted specific immunity 
against chronic LCMV infection70. Interestingly, selective TNF receptor expression on T cells was shown to be 
responsible for T cell exhaustion.
In conclusion, our results demonstrate that while sustained p55TNFR expression mediated normal acute control 
of acute M. tuberculosis infection, it was associated with suboptimal T cell responses during chronic infection and 
promoted tuberculosis reactivation.
Methods
Mice. C57BL/6 wild type (WT) and p55∆NS mice34 were maintained and housed in individually ventilated 
cages under specific pathogen free conditions in the Research Animal Facility at the University of Cape Town 
(South Africa). For all the experiments, age matched mice were used.
Ethics statement. All experiments and protocols were approved and performed in accordance with the 
guidelines of the Research Ethics Committee of the University of Cape Town, South Africa and complied with 
South African regulations as stipulated in The South African National Standard 10386-The care and use of animals 
for scientific purposes.
Mycobacteria and infection. M. tuberculosis H37Rv was grown in Middlebrook 7H9 broth (Becton, 
Dickinson and Company, Le Pont de Claix, France) supplemented with 10% Middlebrook OADC enrichment 
medium (Life Technologies, Gaitherburg, MD), 0.5% glycerol and 0.05% Tween 80 at 37 °C until log phase. 
H37Rv-GFP (kindly provided by Joel Ernst, University of San Fransciso, California) was grown similarly with 
25 mg/L kanamycin in the broth. Prior to use, mycobacterial aliquots were passed 30× through a 29.5G needle 
to minimize bacterial clumping. Pulmonary infection at a dose of 50–100 live M. tuberculosis H37Rv bacilli was 
performed using a Glas-Col Inhalation Exposure System, Model A4224. Inoculum dosage was confirmed 24 h 
post-infection by determining the bacilli burden in the lungs of infected mice. To establish a latent infection, mice 
were treated with 25 mg/Kg INH-RIF for 6 weeks commencing at day 28 post- infection, which resulted in unde-
tectable levels of bacilli. For disease reactivation, chemotherapy was withdrawn and bacilli burdens determined at 
day 90, 180 and 300 days post infection. For colony enumeration organs were weighed and homogenized in 0.04% 
Tween 80/PBS. Tenfold serial dilutions of organ homogenates were plated in duplicates on Middlebrook 7H10 
(Becton, Dickinson and Company) agar plates containing 10% OADC (Life Technologies, Gaitherburg, MD) and 
incubated at 37 °C for 19–21 days.
Lung Morphology. Lung weights were measured for use as a surrogate marker of inflammation, and thereafter 
fixed in 10% formalin and paraffin-embedded. Tissues were sectioned at 2–3 μ m and stained with haematoxylin 
and eosin (H&E), then analysed using a Nikon 90i Eclipse microscope. The percentage of free alveolar space was 
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calculated based on the area measurement using the microscope imaging software NIS-Elements, Nikon to ana-
lyze the open space in the whole lung section.
Cytokine ELISA. Whole lungs were homogenized in 1 ml 0.04% Tween 80 saline containing protease inhibitor 
(Sigma) and the supernatants, aliquoted and frozen at − 80 °C. Cytokine concentrations were measured in 
organ homogenates or supernatants from cultured cells using commercially available ELISA reagents for TNF, 
p55TNFR, p75TNFR, IFNγ , and IL-12p70, (R&D Systems, Germany and BD Pharmingen, San Diego), according 
to the manufacturer’s instructions.
Lung single cell preparation and Flow cytometry. Lungs from infected mice were perfused by injecting 
5 ml cold PBS containing 20 U/ml heparin (Bodene (PTY) Limited, RSA) in the right ventricle of the heart. 
Lungs were removed, sectioned and incubated in PBS containing 50 U/ml collagenase 1 (Worthington Biomedical 
Coorporation, Lakewood, NJ) and 13 μ g/ml DNAse 1 (Boeringer-Mannheim, Germany) at 37 °C for 90 min with 
rotation. For single cell suspension, lung tissue was passed through a 70 μ m nylon cell strainer (Beckton and 
Dickinson), washed 2× with PBS and viable cell numbers were determined by counting in the presence of trypan 
blue.
Isolated lung cells from infected mice were stained with the following antibodies: anti-CD3 BV421 
(145-2C11), anti-CD4-FITC (H129.19), anti-CD4 Alexo-fluor 700 (RM4-5), anti-CD44-PE (IM7), anti-CD86-PE 
(GL1), anti-CD80-PE (16-10A1), anti-I-A/I-E-PE (M5/14.15.2), anti-CD11b-FITC. All the antibodies were 
purchased from Pharmingen and used at 2 μ g/ml/106 cells. Cells were fixed in 4% paraformaldehyde and were 
acquired using a FACS Calibur or BD LSR Fortessa (Beckton and Dickinson) and analyzed using FlowJo 7.5 soft-
ware (Tree star, Ashland, OR, USA).
Peritoneal macrophages. Mice were injected with 3% thioglycollate (Difco, St. Louis, USA). Five days 
later, peritoneal exudate cells were isolated from the peritoneal cavity by washing with ice-cold RPMI (Sigma, 
Germany) supplemented with 10% FCS (Gibco, Invitrogen Corporation, Germany). Cells were cultured over-
night at 37 °C and 5% CO2 incubator. Adherent monolayer cells were used as peritoneal macrophages and were 
cultured at 5 × 105 cells/ml in RPMI supplemented with 10% FCS and stimulated for 20 min with either 100 ng/ml 
LPS (E. coli, serotype O111:B4, Sigma) or M. tuberculosis H37Rv (MOI 2:1).
Primary macrophage cultures. Bone marrow cells were isolated from femurs of 6 to 8 weeks old naive 
mice and were cultivated on 90 mm Sterilin plates (Bibby Sterilin, UK) at 2 × 106 cells/ml for 7 days in RPMI 
(Sigma, Germany) supplemented with 2 mM L-glutamine (Gibco, Invitrogen Corporation, Germany), 0.2 μ M 
2-ME (Sigma, St. Louis, USA), 20% horse serum (Gibco, Invitrogen Corporation, Germany) and 30% L929 
cell-conditioned medium at 37 °C and 5% CO2. Confluent cells were harvested and seeded at 5 × 105 cells/ml in 
96 well tissue culture plates (Nunclon, Denmark) and incubated for 24 h at 37 °C and 5% CO2 to allow for cell 
adherence. Cells were then stimulated with either 100 ng/ml LPS (E. coli, serotype O111:B4, Sigma) or live M. 
tuberculosis H37Rv bacteria (MOI 2:1) for 90 min, 150 min, 300 min, 24 h, and 48 h. Supernatants were collected 
and analysed for cytokine content using ELISA and nitrite concentration using Griess reagent (3% phosphoric 
acid, 1% p-aminobenzene-sulphonamide, 1% n-naphthylenediamide) as described71.
To determine bactericidal capacity to kill M. tuberculosis bacilli, BMDMs were infected with H37Rv-GFP 
at 2:1 MOI for 4 to 120 hours. The amount of intracellular bacilli was determined by lysing the mac-
rophages and measuring the relative fluorescent unit (RFU) using Modulus microplate fluorometer (Turner 
Biosystems Inc.).
BAL collection. Mice were euthanized to reveal the trachea. BAL fluid was collected by 2 lavages in which an 
18-gauge cannula was inserted into the trachea and aspirated 10 times with 300 μ l sterile PBS. The BAL fluid was 
aliquoted and stored at − 80 °C for cytokine analysis. BAL cells were collected by 3 lavages with 700 μ l sterile PBS 
each. Cells were kept on ice for flow cytometric analysis.
Bioactive TNF assay. Bioactive TNF was determined as previously described16, using TNF sensitive 
fibroblast cell line WEHI 164, clone 13 (Walter and Eliza Hall Institute). WEHI cells were cultured in RPMI 
(Sigma, Germany) containing 10% FCS (Gibco, Invitrogen Corporation, Germany), 10 U/ml penicillin (Gibco, 
Germany), 10 μ g/ml streptomycin (Gibco, Invitrogen Corporation, Germany) and 0.5× amino acid supplement 
(MEM Amino acids without L-glutamine, Gibco, Germany) at 37 °C with 5% CO2. Confluent cells were reseeded 
at 2 × 105 cells/ml in 96 well tissue culture plates (Nunclon, Denmark). TNF standards (recombinant mouse TNF, 
BD PharMingen, San Diego) in 2 fold serial dilutions or samples were added to WEHI cells and incubated for 18 h 
at 37 °C with 5% CO2. MTT solution (2 mg/ml, Sigma, Germany) was then added and incubated for a further 2 h, 
after which, the supernatants were aspirated and 50 μ l DMSO was added and samples were read at 570 nm using 
VERSAmax Tunable Microplate Reader (Molecular devices Coorporation, California, USA). Data was analyzed 
using SoftMax Pro (Molecular devices Coorporation, California, USA).
Statistical Analysis. Statistical analysis was performed using Graphpad Prism 6 by ANOVA. For mortality 
studies, analysis was performed using the logrank test. For all tests, a p value of < 0.05 was considered significant.
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